Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03596866
Brief Title: An Efficacy Study Comparing Brigatinib Versus Alectinib in Advanced Anaplastic Lymphoma Kinase-Positive (ALK+) Non-Small-Cell Lung Cancer (NSCLC) Participants Who Have Progressed on Crizotinib (ALTA-3)

First Submitted : July 13, 2018
First Submitted that Met QC Criteria : July 13, 2018
First Posted : July 24, 2018

Last Update Submitted that Met QC Criteria : September 26, 2019
Last Update Posted : September 30, 2019